Dendritic cell vaccines for cancer therapy: fundamentals and clinical trials

GG Romagnoli, R Kaneno - … Bench to Bedside Immunotherapy of Cancers, 2021 - Springer
Since conventional chemo-and radiotherapy and surgery are not completely satisfactory to
fight cancer, active and passive immunotherapeutic approaches have figured as effective …
被引用次数：2 相关文章

18 Dendritic Cell Vaccines for Cancer Therapy: Fundamentals and Clinical Trials

GG Romagnoli, R Kaneno - Cancer Immunology: Bench to …, 2020 - books.google.com
These cells are subdivided into CD1c+(BDCA1+ cells) and CD141+(BDCA3+) subsets [13,
14]. Maturation/activation of these cells is character-ized by the expression of CD80, CD86 …

Dendritic Cell Vaccines for Cancer Therapy: Fundamentals and Clinical Trials

GG Romagnoli, R Kaneno - … Bench to Bedside Immunotherapy of Cancers, 2015 - Springer
One of the main challenges in antitumor immunotherapy is the low immunogenicity of tumor
cells and the tolerogenic tumor microenvironment. The central role of dendritic cells (DCs) …

Dendritic cell vaccines for cancer therapy: Fundamentals and clinical trials

GG Romagnoli, R Kaneno - Cancer Immunology: Bench to …, 2020 - repositorio.unesp.br
Since conventional chemo-and radiotherapy and surgery are not completely satisfactory to
fight cancer, active and passive immunotherapeutic approaches have figured as effective …

Dendritic cell vaccines for cancer therapy: Fundamentals and clinical trials

GG Romagnoli, R Kaneno - 2020 - repositorio.unesp.br
Since conventional chemo-and radiotherapy and surgery are not completely satisfactory to
fight cancer, active and passive immunotherapeutic approaches have figured as effective …